Work

Response-Adaptive Phase II Study of Daratumumab Combined with Carfilzomib, Lenalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma

Year: 2020

Type: article

Source: Blood

DOI: 10.1182/blood-2020-138485

Authors: Manisha Bhutani, Monika House, Jiaxian He, Shebli Atrash, David M Foureau, Barry Paul, Reed Friend, James T Symanowski, Sarah Norek, Xhevahire Begic, Donna Acampora, Katherine K Farmer, Carrie Ann Syfert, Mauricio Pineda-Roman, Peter Voorhees, Saad Z. Usmani

Institution: Levine Cancer Institute

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3096672838

FWCI: 0.545

Cites:

Cited by: 6

Related to: 10